The Pharmacogenomics Journal - Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia Skip to main content Thank you for visiting nature.com.

Background: Mucositis is an important morbidity that may affects quality of life, impairs the chemotherapy dose intensity and may causes fatal infective complications. Methotrexate (MTX) is an ...

British Journal of Cancer - Methotrexate, ... (46.7%) and grade 3 or 4 mucositis in four (13.3%); most nonhaematologic toxicities were confined to grade 1 or 2 .

Some people have concerns about access to methotrexate now that Roe v. Wade has been overturned. Here’s how the medication is used, plus possible side effects.

The ACR20 response rate at 24 weeks was higher in the tocilizumab-methotrexate combination therapy (52.9%) and tocilizumab monotherapy (50.0%) groups than in the methotrexate monotherapy group (25 ...